Polifenoles Naturales, S.L., known as PoliNat, a Spanish company based in the Canary Islands, is proud to announce the recent issuance of its U.S. Patent #8,367,072 for Xanthigen.
Polifenoles Naturales, S.L., known as PoliNat, a Spanish company based in the Canary Islands, is proud to announce the recent issuance of its U.S. Patent #8,367,072 for Xanthigen. The U.S. Patent and Trademark Office issued the patent, titled “Composition for treating obesty and method of using the same.” According to Miguel Jimenez del Rio, PhD, president and CEO of PoliNat, “It’s gratifying that Xanthigen has been recognized as being unique enough to earn a patent. We’ve always felt that way and now Xanthigen has official recognition.” Learn more about Xanthigen at the Polinat/P.L. Thomas booth #24060 at Vitafoods Europe.
P.L. ThomasBooth 24060
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.